Long-term administration appears to be generally well tolerated among research subjects, according to a 2008 study as well as one from 2010.10 11 To be clear, tesamorelin isnt free of adverse events, and it isnt appropriate for everyone, but its risks are few and mild compared to many prescription treatments
Furthermore, there is often a lack of adequate functional information to validate candidate mutations or determine which gene variant, sometimes among multiple potential candidates, is causing a patients disease
This suggests the drug was engaging relevant pathways, just not sufficiently to translate to clinical benefit at this disease stage
What Is Glutathione (And Why Should You Care)
This triple-agonist approach, targeting GLP-1, GIP, and glucagon receptors, produced the most dramatic weight loss results seen in any Phase 2 obesity trial